Highly diastereoselective SE' additions of enantioenriched allenylstannanes to (S)-2-(benzyloxy)propanal
摘要:
The BF3-promoted addition of (S)-allenylstannane (S)-6 to aldehyde 16 afforded a 68:32 mixture of diastereomeric homopropargylic alcohols 17 and 18 whereas MgBr2-promoted addition gave adduct 17 as the exclusive product. The (R)-allenylstannane (R)-6, on the other hand, yielded a 30:1 mixture of syn and anti alcohol adducts 19 and 20 with BF3.OEt2 and a 1:92 mixture favoring the anti adduct 20 under MgBr2 catalysis.
Highly diastereoselective SE' additions of enantioenriched allenylstannanes to (S)-2-(benzyloxy)propanal
摘要:
The BF3-promoted addition of (S)-allenylstannane (S)-6 to aldehyde 16 afforded a 68:32 mixture of diastereomeric homopropargylic alcohols 17 and 18 whereas MgBr2-promoted addition gave adduct 17 as the exclusive product. The (R)-allenylstannane (R)-6, on the other hand, yielded a 30:1 mixture of syn and anti alcohol adducts 19 and 20 with BF3.OEt2 and a 1:92 mixture favoring the anti adduct 20 under MgBr2 catalysis.
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
申请人:Castro C. Alfredo
公开号:US20060025460A1
公开(公告)日:2006-02-02
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Isoxazolidine compounds for treatment of bacterial infections
申请人:Christensen G. Burton
公开号:US20060020004A1
公开(公告)日:2006-01-26
The present invention relates to antibiotic compounds and intermediates useful in their preparation. Many of the antibiotic compounds contain a substituted isoxazolidine ring. The invention also relates to pharmaceutical compositions containing a compound of the invention. The invention further provides processes for the preparation of compounds of the invention, and methods for their use as therapeutic agents.
Synthesis of enantioenriched homopropargylic alcohols through diastereoselective SE' additions of chiral allenylstannanes to aldehydes
作者:James A. Marshall、Xiao Jun Wang
DOI:10.1021/jo00030a036
日期:1992.2
Allenylstannanes (S)-4 and (R)-4, available in ca. 90% ee from alkynones 1 through reduction with the LiAlH4-Darvon alcohol or -ent-Darvon alcohol complex, followed by S(N)2' displacement on the derived mesylates (R)-3 or (S)-3 with Bu3SnLi.CuBr.Me2S, readily add to various aldehydes under Lewis acid catalysis to afford optically active homopropargylic alcohols with good to excellent syn diastereoselectivity. With 2-(benzyloxy)propanal (48), MgBr2-catalyzed reactions are highly stereoselective, affording the syn adduct 49 from the (S)-stannane (S)-4 and the anti adduct 52 from the (R)-stannane (R)-4. BF3-promoted additions give mainly or exclusively the syn adducts 49 and 51. Additions of (S)- and (R)-4 to (R)-3-(benzyloxy)-2-methylpropanal (61) yield the syn adducts 62 and 64 as major or exclusive products.
Highly diastereoselective SE' additions of enantioenriched allenylstannanes to (S)-2-(benzyloxy)propanal
作者:James A. Marshall、Xiao Jun Wang
DOI:10.1021/jo00010a007
日期:1991.5
The BF3-promoted addition of (S)-allenylstannane (S)-6 to aldehyde 16 afforded a 68:32 mixture of diastereomeric homopropargylic alcohols 17 and 18 whereas MgBr2-promoted addition gave adduct 17 as the exclusive product. The (R)-allenylstannane (R)-6, on the other hand, yielded a 30:1 mixture of syn and anti alcohol adducts 19 and 20 with BF3.OEt2 and a 1:92 mixture favoring the anti adduct 20 under MgBr2 catalysis.